Stocks of 10x Genomics - Current price, Where to buy? Chart
Detail | Data |
---|---|
Stocks: | 10x Genomics |
ompany Name: | 10x Genomics, Inc. |
Ticker: | TXG |
Exchange: | NasdaqGS |
Outstanding stocks: | 105,110,000 |
24-hour Volume: | 945,070 |
Industry: | Health Information Services |
Sector: | Healthcare |
Number of Employees: | 1259 |
Country: | United States |
City: | Pleasanton |
Address: | 6230 Stoneridge Mall Road |
P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
---|---|---|---|---|---|
/ | -38.65 | -2.18 USD | -0.94 USD | 6.22 USD | 4,328,741,376.00 USD |
P/E Ratio: | / |
---|---|
Forward P/E: | -38.65 |
EPS: | -2.18 USD |
Forward EPS: | -0.94 |
Book value per share: | 6.22 USD |
Market capitalization: | 4,328,741,376.00 USD |
10x Genomics
Fundamental Indicators
Indicator | Data |
---|---|
Total Revenue: | 618,726,976.00 USD |
Net Income: | -255,099,008.00 USD |
Price-to-Book (P/B) Ratio: | 5.84 |
PEG Ratio: | -0.45 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
Analysts | Recommendation |
---|---|
Issued Recommendation: | According to our data, the recommendation issued for 10x Genomics stocks is: buy |
Number of Analysts: | 14 |
Highest Target Price: | 70 USD |
Lowest Target Price: | 30 USD |
Average Target Price: | 60 USD |
Note: The data is approximate. Recommendations and price forecasts for 10x Genomics stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
Dividends | Value |
---|---|
Dividend Amount | According to our data, the company 10x Genomics is currently not paying dividends. |
Annual Yield %: | - |
Ex-dividend Date: | - |
Average % Yield for 5 Years: | - |
Payout Ratio: | - |
Value of Last Dividend Paid: | - |
Date of Last Dividend: | - |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy 10x Genomics Stocks?
If you're interested in investing in 10x Genomics stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of 10x Genomics stocks through mobile apps with client support. In this table, you can compare brokers offering real 10x Genomics stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
---|---|---|---|---|---|---|---|
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller | Go to eToro | ||||
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer | Go to XTB |
xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
Go to XTB | Go to eToro |
More Information about 10x Genomics (TXG)
Revenues of 618,726,976.00 USD indicate room for growth and improvement for 10x Genomics. This presents an opportunity for further development. Negative EBITDA of -159,436,992.00 USD may indicate challenges but also opportunities for 10x Genomics to invest in future growth. Debt-to-equity ratio of 0.13 suggests that 10x Genomics has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 66.15% shows that 10x Genomics efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Lower profit margin of -41.23% suggests opportunities for 10x Genomics to increase efficiency and reduce costs.
Indicator | Value |
---|---|
Revenue, Debt, and Cash Flow | |
Company Revenue: | 618,726,976.00 USD |
EBITDA: | -159,436,992.00 USD - Negative EBITDA may signal financial challenges or growth investments. |
Earnings Per Share: | -2.18 USD |
Book Value Per Share: | 6.22 USD |
Total Cash: | 388,695,008.00 USD |
Total Cash per Share: | 3.26 USD |
Total Debt: | 95,370,000.00 USD |
Debt to Equity Ratio: | 0.13 |
Quick Ratio: | 3.96 |
Current Ratio: | 4.69 |
Free Cash Flow: | 30,626,250.00 USD |
Operating Cash Flow: | -15,197,000.00 USD |
Company Margins | |
Gross Margins: | 66.15 % |
EBITDA Margins: | -25.77 % |
Operating Margins: | -15.76 % |
Profit Margins: | -41.23 % |
Performance | |
Return on Assets: | -12.2 % |
Return on Equity: | -33.0 % |
Earnings Growth (1 year): | / |
Revenue Growth (1 year): | 17.8 % |
Year-over-Year Quarterly Earnings Growth: | / |
Valuation | |
Market Capitalization: | 4,328,741,376.00 USD |
Enterprise Value: | 4,035,995,648.00 USD |
EV/Revenue: | 6.523 |
EV/EBITDA: | -25.314 |
Number of Shares and Short Shares | |
Float Shares: | 102,632,186 shares |
Shares Outstanding: | 105,110,000 shares |
Held Percent Insiders: | 0.02 % |
Held Percent Institutions: | 92.50 % |
Shares Short: | 6,891,767 |
Shares Short Prior Month: | 6,658,579 |
Date Short Interest: | 2024-02-29 |
Shares Percent Shares Out: | 5.78 % |
Short Ratio: | 5.22 |
Beta: | 1.92 |
Short Percent of Float: | 8.22 % |
Předpokládaný počet akcií: | 122,154,000 |
Frequently Asked Questions (FAQ)
According to our data, 10x Genomics does not currently pay dividends, even in 2024.
10x Genomics shares are traded on the stock exchange NasdaqGS under the ticker symbol: TXG. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a buy recommendation issued for 10x Genomics shares by a total of 14 analysts. The average target price prediction is 60 USD per share.
The total number of 10x Genomics shares on the exchange is 105,110,000.00, which, at the current market capitalization, values the company at 4,328,741,376.00 USD.